Development of a low-cost, point-of-need molecular test for flu a+b and self-collected swab specimens.
Active Definitive Contract Awarded Last action
- Contract number
- 75A50124C00055
- Awardee
-
Sherlock Biosciences, Inc. UEI Z1K6AV77QHV5
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $3,079,315
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 30% obligated
-
- $3,079,315.00 Current, with exercised options
- $10,305,092.00 Potential, with all options
- Completion date 61% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Sharing
- Place of performance
- Watertown, MA 02472, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $930,341 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,148,974 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a $10.305 million definitive contract to Sherlock Biosciences, Inc. for development of a low-cost, point-of-need molecular test for influenza A and B using self-collected swab specimens on September 30, 2024.
The contract carries cost-sharing pricing and no set-aside. Place of performance is Watertown, MA. The originating solicitation emerged from a Broad Agency Announcement by the Biomedical Advanced Research and Development Authority (BARDA) seeking advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats, with proposals evaluated on technical merit, relevance to BARDA's mission, and available funding. The ultimate completion date is February 24, 2028.
Slieagen LLC is a subcontractor providing clinical samples for assay validation.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Slieagen LLC | $18,000 |
Quick answers
Who was awarded contract 75A50124C00055?
75A50124C00055 was awarded to Sherlock Biosciences, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2024.
How much is contract 75A50124C00055 worth?
The government has obligated $3,079,315 on 75A50124C00055. Its potential value, with all options, is $10,305,092.
Was contract 75A50124C00055 competed?
The extent of competition for 75A50124C00055 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award